SCHEMBL1895989

SCHEMBL1895989

NC1C[CH]NCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20403378 0.74
SCHEMBL7069961 0.71
SCHEMBL3369552 0.67
SCHEMBL8181241 0.64
SCHEMBL16619685 0.62
SCHEMBL2041398 0.62
SCHEMBL6435025 0.60 HTR6 (0.42)
SCHEMBL1882056 0.59
SCHEMBL62516 0.59
SCHEMBL385141 0.57

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8435987-B2 Pyrazolo-pyridinone and pyrazolo-pyrazinone compounds as P38 modulators and methods of use thereof AMGEN INC. (US) 2013-05-07 US disclosed
US-20110294805-A1 PYRAZOLO-PYRIDINONE AND PYRAZOLO-PYRAZINONE COMPOUNDS AS P38 MODULATORS AND METHODS OF USE THEREOF AMGEN INC. (US) 2011-12-01 US disclosed
US-8022085-B2 Pyrazolo-pyridinone and pyrazolo-pyrazinone compounds as P38 modulators and methods of use thereof AMGEN INC. (US) 2011-09-20 US disclosed
US-20110105498-A1 Pyrazolo-pyridinone and pyrazolo-pyrazinone compounds as P38 modulators and methods of use thereof AMGEN INC. (US) 2011-05-05 US disclosed